N-ethyl-4-hydroxyl-1-methyl-5-(methyl (2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-ethyl-4-hydroxyl-1-methyl-5-(methyl (2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide
• 英文别名: N-ethyl-4-hydroxy-1-methyl-5-[methyl-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]-2-oxo-N-phenylquinoline-3-carboxamide
• 化学式: C₂₆H₃₃N₃O₈
• 分子量: 515.563
• InChiKey: RSJNDADBGUDAQN-TWRVUUBYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  37
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  165
• 氢给体数：
  6
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  5-iodo-laquinimod 、 N-甲基-D-葡胺 在 copper(l) iodide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 以38%的产率得到N-ethyl-4-hydroxyl-1-methyl-5-(methyl (2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide
  参考文献：
  名称：

  [EN] N-ETHYL-4-HYDROXYL-1-METHYL-5- (METHYL(2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) -2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE
  [FR] N-ETHYL-4-HYDROXYL-1-MÉTHYL-5-(MÉTHYL(2,3,4,5,6-PENTAHYDROXYHEXYL)AMINO)-2-OXO-N-PHÉNYL-1,2-DIHYDROQUINOLÉINE-3-CARBOXAMIDE

  摘要：

  公开号：

  WO2013169746A3

文献信息

• US20140271878A1
  申请人：——

  公开号：US20140271878A1

  公开（公告）日：2014-09-18
• CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF
  申请人：Frenkel Anton

  公开号：US20160158216A1

  公开（公告）日：2016-06-09

  The subject invention provides a mixture of crystalline laquinimod sodium particles, wherein (i) 90% or more of the total amount by volume of the laquinimod sodium particles have a size of 40 microns or less or (ii) 50% or more of the total amount by volume of the laquinimod sodium particle have a size of 15 microns or less, and wherein: a) the mixture has a bulk density of 0.2 g/mL to 0.4 g/mL; b) the mixture has a tapped density of 0.40 g/mL to 0.7 g/mL; c) an amount of heavy metal in the mixture is no more than 0.002% of heavy metal relative to the amount by weight of laquinimod sodium; d) an amount of 5-chloro-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline (MCQ) in the mixture is no more than 0.15% relative to the amount of laquinimod sodium as measured by HPLC; e) an amount of 5-chloro-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid (MCQCA) in the mixture is no more than 0.15% relative to the amount of laquinimod sodium as measured by HPLC; or f) an amount of 5-chloro-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate (MCQME) in the mixture is no more than 0.12% relative to the amount of laquinimod sodium as measured by HPLC.
• US8809537B2
  申请人：——

  公开号：US8809537B2

  公开（公告）日：2014-08-19
• US9233927B2
  申请人：——

  公开号：US9233927B2

  公开（公告）日：2016-01-12
• [EN] N-ETHYL-4-HYDROXYL-1-METHYL-5- (METHYL(2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) -2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE<br/>[FR] N-ETHYL-4-HYDROXYL-1-MÉTHYL-5-(MÉTHYL(2,3,4,5,6-PENTAHYDROXYHEXYL)AMINO)-2-OXO-N-PHÉNYL-1,2-DIHYDROQUINOLÉINE-3-CARBOXAMIDE
  申请人：TEVA PHARMA

  公开号：WO2013169746A3

  公开（公告）日：2013-12-05